[HTML][HTML] Impact of the COVID-19 pandemic on tuberculosis control: an overview

KA Alene, K Wangdi, ACA Clements - Tropical medicine and infectious …, 2020 - mdpi.com
Throughout history, pandemics of viral infections such as HIV, Ebola and Influenza have
disrupted health care systems, including the prevention and control of endemic diseases …

Global burden of melioidosis in 2015: a systematic review and data synthesis

E Birnie, HS Virk, J Savelkoel, R Spijker… - The Lancet Infectious …, 2019 - thelancet.com
Background Melioidosis is an infectious disease caused by the environmental bacterium
Burkholderia pseudomallei. It is often fatal, with a high prevalence in tropical areas. Clinical …

[HTML][HTML] Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae

NA Menzies, M Quaife, BW Allwood… - The Lancet Global …, 2021 - thelancet.com
Background Many individuals who survive tuberculosis disease face ongoing disability and
elevated mortality risks. However, the impact of post-tuberculosis sequelae is generally …

[PDF][PDF] WHO operational handbook on tuberculosis: module 4: treatment: drug-susceptible tuberculosis treatment

World Health Organization - 2022 - apps.who.int
WHO operational handbook on tuberculosis Page 1 WHO operational handbook on
tuberculosis Module 4: Treatment Drug-susceptible tuberculosis treatment Page 2 WHO …

[HTML][HTML] Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study …

JR Ledesma, J Ma, A Vongpradith… - The lancet infectious …, 2022 - thelancet.com
Background Tuberculosis is a major contributor to the global burden of disease, causing
more than a million deaths annually. Given an emphasis on equity in access to diagnosis …

[HTML][HTML] Global, regional, and national burden of tuberculosis, 1990–2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study

HH Kyu, ER Maddison, NJ Henry… - The Lancet Infectious …, 2018 - thelancet.com
Background Although a preventable and treatable disease, tuberculosis causes more than a
million deaths each year. As countries work towards achieving the Sustainable …

The double burden of diabetes and global infection in low and middle-income countries

S Dunachie, P Chamnan - Transactions of The Royal Society of …, 2019 - academic.oup.com
Four out of five people in the world with diabetes now live in low-and middle-income
countries (LMIC), and the incidence of diabetes is accelerating in poorer communities …

2018 update of the APLAR recommendations for treatment of rheumatoid arthritis

CS Lau, F Chia, L Dans, A Harrison… - … journal of rheumatic …, 2019 - Wiley Online Library
Aim To update recommendations based on current best evidence concerning the treatment
of rheumatoid arthritis (RA), focusing particularly on the role of targeted therapies, to inform …

[HTML][HTML] Impact of socio-economic factors on Tuberculosis treatment outcomes in north-eastern Uganda: a mixed methods study

J Nidoi, W Muttamba, S Walusimbi, JF Imoko… - BMC Public Health, 2021 - Springer
Background Tuberculosis (TB) is a major public health problem and at 48%, Karamoja in
North-Eastern Uganda has the lowest treatment success rate nationally. Addressing the …

[HTML][HTML] HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis

ZZ Sultana, FU Hoque, J Beyene… - BMC infectious …, 2021 - Springer
Background Multidrug-resistant tuberculosis (MDR-TB) in HIV infected individuals is a
serious threat to global efforts to combat tuberculosis. Inconsistent findings on the …